
Unprepared for another Covid: Defunct medical oxygen infrastructure
Unpreparedness
: During the COVID-19 pandemic, India swiftly mobilised emergency
medical oxygen infrastructure
across the country.
Plants and systems were rapidly commissioned to meet the unprecedented demand.
However, whatever infrastructure was put up during the pandemic is now largely defunct, owing to lack of maintenance, fragmented operations, and insufficient regulatory clarity.
No programs are drawn to train and upskill the healthcare professionals in operating and maintenance of PSA generators.
As a result, many of these systems cannot deliver the required purity of medical oxygen— providing nothing more than compressed air.
Over the last three years all of the generators have mostly neither be regularly operated nor serviced. Mock drills failed to restart this defunct machinery. This has led to a growing dilemma among the medical fraternity.
Health Directors across all the Indian states unanimously acknowledge this concern. It signals an urgent need to reimagine how the nation prepares for future health emergencies for medical oxygen —especially in rural regions where the challenges are acute and critical.
Two important lessons learnt from COVID –
1. The need to minimize the migration of patients from villages to cities.
2. Need to strengthen public healthcare infrastructure with innovative and India centric technologies to address the emerging challenges.
Decentralization
: Nearly 65 per cent of India's population resides in villages, where even now access to medical oxygen remains limited. Their availability at the right time and place can mean the difference between life and death.
The lack of decentralized oxygen infrastructure forces patients to travel long distances to urban centres, often under dire circumstances.
This not only worsens outcomes including exploitation but also places an unsustainable burden on territory hospitals which are mostly in cities.
Adding medical oxygen generating capacities is not the solution. The nuance is in understanding that oxygen cylinders save more lives!!
This justifies decentralization through commissioning containerised mobile PSA cylinder filling stations at every District headquarters.
This will effectively maintain the supply chain logistics of medical oxygen cylinders up to the PHC level hospitals where required and beyond in their respective districts. These containerised plants will get
seamlessly integrated with the existing infrastructure and also meet the demand for refilling of medical oxygen cylinders, without remaining idle and contributing to the state exchequer.
Deregulation
: The path to addressing the future challenges requires more than infrastructure—it requires regulatory reform in equal measure.
Central Government has last month released new guidelines 'Medical Oxygen Management' however, a critical lacuna remains—Without provisions for mobile cylinder filling stations, such guidelines risk being disconnected from the practical challenges on the ground.
There is an urgent need for the health ministry to put up a strong representation to the ministry of commerce and industry (under which the PESO regulates) to bring in suitable amendments and frame new guidelines to include Mobile containerised PSA captive oxygen generation plants, in keeping with the global practices.
This is critical in building a resilient healthcare infrastructure for our country.
Medical Oxygen Grid
: The post-COVID era demands a fresh blueprint, one that can address the twin challenges of preparedness and last-mile delivery.
To address this, CPDMED, TBI at the Indian Institute of Science, Bangalore has developed a comprehensive national level model focused on strengthening medical oxygen readiness and response across the country.
At the heart of this initiative is the creation of a
Medical Oxygen Grid
—a decentralized system of containerised captive oxygen plants with inbuilt cylinder refilling stations, positioned at every district headquarters.
Designed for a resilient plug-and-play use, such modular units can be swiftly integrated into existing healthcare infrastructure and in emergency moved to any secondary hospitals, filling a long-standing gap in India's emergency preparedness.
Beyond civilian healthcare, the proposed grid has significant strategic importance. In times of war or natural calamities, this network can serve as a reliable support system for the defence forces and Humanitarian Assistance and Disaster Relief (HADR) application.
Skilling Programme
: CPDMED has designed a comprehensive national level training programme for skilling and training healthcare professionals. It is offering a certified training progamme on its campus.
Leveraging Technology
: Our vision bridges this gap through technology and data driven tools. By leveraging geospatial mapping, IoT-based monitoring systems, hub and-spoke distribution models, and predictive analytics, the Medical Oxygen Grid can ensure real-time visibility, accountability, and responsiveness across the supply chain.
This digital backbone will be key in transforming the way oxygen is produced, distributed, and consumed—district by district, facility by facility.
We propose this National grid will be driven by a Toll-Free number that will ensure
:
▪
Availability
: 24x7x365 days
▪
Accessibility
: Till the last village and the last patient at home.
▪
Accountability
: ensuring correct volume, pressure and purity of oxygen.
▪
Affordability
: at DPCO rates.
India stands at a crossroads. The near defunct state of existing epidemic ready infrastructure is a wake-up call—not a failure, but a powerful reminder of the need to build smart, resilient, and sustainable systems.
A decentralized, digitally empowered Medical Oxygen Grid offers not only a solution, but a national strategy to strengthen medical oxygen delivery, protect rural lives, and support national security.
This article is written by Dr. Srinivas M Kandada, Principal Consultant & Head of Operations-CPDMED, IISc Bangalore
(DISCLAIMER: The views expressed are solely of the author and ETHealthworld.com does not necessarily subscribe to it. ETHealthworld.com shall not be responsible for any damage caused to any person/organisation directly or indirectly)

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Hans India
18 minutes ago
- Hans India
Shaheen Group secures 500 MBBS seats for Indian students in Tajikistan
Hyderabad: As hundreds of students fail to secure MBBS seats through merit or management quotas, Shaheen Group of Institutions has signed a Memorandum of Understanding (MoU) with the Medical Social Institute of Tajikistan, under which 500 students will be able to pursue MBBS degrees at the institute. As part of the collaboration, the Ambassador of Tajikistan to India, along with the Cultural Ambassador and other diplomatic representatives, visited the Shaheen Campus. Dr Zainab, the Tajikistan coordinator, assured that full security is provided to international students there. Dr Abdul Qadeer, Chairman of the Shaheen Group of Institutions, explained that this agreement offers such students a chance to fulfill their dream of becoming doctors. He further stated that students can complete the entire six-year MBBS course, including hostel accommodation and Indian food, for just Rs 32 lakh. Dr Qadeer shared that the course fee can be paid in easy installments. The registration fee is Rs 49,500, and registrations will remain open until the end of June. The Rs 32 lakh package also includes insurance coverage. In a significant move, Shaheen Group and its medical partners will provide FMGE (Foreign Medical Graduate Examination) coaching from the first day of the MBBS course. This ensures that students are well-prepared to obtain a license for medical practice after graduation. For more information, visit:


News18
38 minutes ago
- News18
No 2020-Like Repeat Of Covid-19, Influenza A Bigger Risk: Ex-WHO Scientist Soumya Swaminathan
Last Updated: Addressing fears of another catastrophic wave, Swaminathan said periodic surges—roughly every 6-8 months—are expected, largely manageable, and low in severity Influenza, and not Covid-19, likely claims more lives each year in India and globally despite the latter dominating headlines, Dr Soumya Swaminathan, former chief scientist at the World Health Organization (WHO), has told News18. One of the leading experts on infectious diseases, Swaminathan has reassured the public that there is 'absolutely no need to panic now". In an exclusive interview, Swaminathan told News18 that the SARS coronavirus, much like influenza, is now part of the respiratory viruses regularly circulating in the population. ' COVID or SARS-CoV-2, which is the virus, is another respiratory virus, like the many others that are circulating amongst us human beings in the world today. It has been around for five years now. It's, of course, constantly mutating and changing, like other viruses," she said. When asked whether there's a possibility of another 'Delta-like' wave making a return, she said the public needs to understand 'very clearly" that 'we will not see the repeat of 2020 or 2021. At that time, human beings had never seen this virus before". According to her, these periodic surges—roughly every 6-8 months—are expected and largely manageable. 'We have also now started seeing that periodically…There is a rise in circulating Covid-19 cases," she noted, citing data from the Indian Council of Medical Research (ICMR), which indicates that the Omicron variant JN.1 has recently become the dominant strain. Swaminathan, before her ground-breaking role at WHO, was the Director General of the Indian Council of Medical Research (ICMR) and secretary of the Department of Health Research in India. She, however, says that despite the increase in cases, the severity remains low. 'What you're seeing now is a mild disease mostly. Even though people are testing and reporting positivity, you find that hospitalisations are rare," she said. Swaminathan highlighted that individuals with underlying health conditions should continue to take precautions. 'People who have underlying illnesses… are likely to get a little sicker when they get a respiratory infection," she warned, adding that this applies to both Covid-19 and influenza. The flu virus may pose a greater threat than Covid-19. 'Influenza probably kills a lot more people in India and around the world… it makes a lot of sense for vulnerable people to take the flu vaccine, which gets updated every year." Addressing fears of another catastrophic wave, she assured the public: 'It will not happen that we will have a repeat of 2020 or 2021… Today, the virus cannot spread in the same way because it is met with a strong immune response." Do we need booster shots or updated vaccines? According to Swaminathan, there is a need to evaluate the efficacy and cost-effectiveness of updating vaccines, especially in countries like India. 'We see that illness is mild, not requiring hospitalisation… There doesn't seem to be any reason to start a booster campaign now," she said, although she acknowledged the importance of preparing for potential future variants through continued research and updated vaccine development. She also outlined five key areas for pandemic preparedness. 'We need new legislation today that will cover biological threats like pandemics," she said, adding that 'India should have its own list of priority pathogens… and mechanisms for developing vaccines and therapeutics". Also, she said: 'Every state must have a public health cadre… It's essential to deal with so many health risks today, along with the improvement of health literacy and public engagement, which is critical." What should you do? 'Let's take sensible precautions… I see people travelling in crowded buses, trains, and planes, coughing and sneezing without a mask—that's just spreading infection." As for concerns about waning immunity, she explained, 'There are two kinds of immunity… antibodies, which decline over time, and T-cells, which have memory. The moment you are exposed again to the same virus… your immune system does its job." She emphasised that Covid-19 is now an endemic part of life. While vigilance and preparedness are necessary, panic is not. 'We can rest assured now… I would say, let's take sensible precautions… but there's no need for any panic." Watch India Pakistan Breaking News on CNN-News18. Get breaking news, in-depth analysis, and expert perspectives on everything from politics to crime and society. Stay informed with the latest India news only on News18. Download the News18 App to stay updated! First Published:


Economic Times
42 minutes ago
- Economic Times
Niva Bupa shares fall 11% as PE investor sells 12% stake in block deal
Shares of Niva Bupa Health Insurance slipped as much as 11.1% on Monday to Rs 82 on the BSE after a large block deal involving a 12% equity stake saw 56.3 lakh shares change hands, as per ETNOW. ADVERTISEMENT Ahead of the trade, on June 1, ET NOW reported, citing sources, that homegrown private equity firm True North and Niva Bupa's Managing Director and CEO, Krishnan Ramachandran, were set to offload a combined 132 million shares in the health insurer through a block deal. ETNOW had also reported that Fettle Tone LLP, an investment vehicle of True North, was expected to sell up to 122 million shares, or roughly 6.7% of Niva Bupa's equity. CEO Krishnan Ramachandran was likely to dilute 10 million shares, equating to around 0.5% of the company. The offer price was set at Rs 82 per share, pegging the total size of the transaction at around Rs 1,082 crore. Based on the latest shareholding pattern as of March-end, the company's promoter Bupa holds 55.98% stake, while True North holds 17.47% via Fettle Tone Bupa reported a 31.2% year-on-year rise in net profit for the March quarter, posting Rs 206 crore compared to Rs 157 crore in the same period last year. Gross premiums increased 18% to Rs 2,078.7 crore, while net premiums climbed 21% to Rs 1,672 the insurer's underwriting profit slipped 12.2% year-on-year to Rs 57.6 crore from Rs 65.6 crore. Operating profit also fell sharply by 43.1% to Rs 94.9 crore from Rs 166.8 crore in the year-ago period. Its solvency ratio stood steady at 3.03% on a sequential basis. ADVERTISEMENT Niva Bupa Health Insurance listed on Indian stock exchanges in November 2024, marking the first domestic listing of a pure-play global MNC health insurer backed by British firm Bupa. In September 2023, True North ceded control to Bupa by selling a 20% stake for approximately Rs 2,700 crore. Also read | Ircon International shares jump over 2% after winning Rs 1,068 crore EPC contract from railways (Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times) ADVERTISEMENT (You can now subscribe to our ETMarkets WhatsApp channel)